Form 6-K-Interim Condensed Consolidated Financial Statements
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of November, 2014

Commission File Number 1-10928

 

 

INTERTAPE POLYMER GROUP INC.

 

 

9999 Cavendish Blvd., Suite 200, Ville St. Laurent, Quebec, Canada, H4M 2X5

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F  x         Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):            

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):            

 

 


Table of Contents

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    INTERTAPE POLYMER GROUP INC.
Date: November 5, 2014     By:  

/s/ Jeffrey Crystal

      Jeffrey Crystal, Chief Financial Officer


Table of Contents

 

Intertape Polymer Group Inc.

Interim Condensed Consolidated Financial Statements

September 30, 2014

 

 

Unaudited Interim Condensed Consolidated Financial Statements

  

Consolidated Earnings

     2   

Consolidated Comprehensive Income

     3   

Consolidated Changes in Shareholders’ Equity

     4 to 5   

Consolidated Cash Flows

     6   

Consolidated Balance Sheets

     7   

Notes to Interim Condensed Consolidated Financial Statements

     8 to 20   


Table of Contents

2

 

Intertape Polymer Group Inc.

Consolidated Earnings

Periods ended September 30,

(In thousands of US dollars, except per share amounts)

(Unaudited)

 

 

 

     Three months ended  
September 30, 
     Nine months ended  
September 30, 
 
     2014       2013       2014       2013   
                     

Revenue

       209,109           199,853           611,982           590,010   

Cost of sales

     168,447        159,872         484,572        469,463   
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit

     40,662        39,981         127,410        120,547   
  

 

 

    

 

 

    

 

 

    

 

 

 

Selling, general and administrative expenses

     23,153        20,547         62,694        63,714   

Research expenses

     1,778        1,701         5,519        4,892   
  

 

 

    

 

 

    

 

 

    

 

 

 
     24,931        22,248         68,213        68,606   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating profit before manufacturing facility closures, restructuring and other related charges

     15,731        17,733         59,197        51,941   

Manufacturing facility closures, restructuring and other related charges (Note 4)

     1,560        934         3,964        29,059   
  

 

 

    

 

 

    

 

 

    

 

 

 

Operating profit

     14,171        16,799         55,233        22,882   

Finance costs (Note 3)

           

Interest

     867        1,261         2,562        4,860   

Other expense, net

     426        190         1,148        787   
  

 

 

    

 

 

    

 

 

    

 

 

 
     1,293        1,451         3,710        5,647   

Earnings before income tax expense

     12,878        15,348         51,523        17,235   

Income tax expense (Note 7)

           

Current

     2,914        729         4,433        3,389   

Deferred

     3,953        200         17,331        114   
  

 

 

    

 

 

    

 

 

    

 

 

 
     6,867        929         21,764        3,503   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net earnings

     6,011        14,419         29,759        13,732   
  

 

 

    

 

 

    

 

 

    

 

 

 

Earnings per share (Note 10)

           

Basic

     0.10        0.24         0.49        0.23   

Diluted

     0.10        0.23         0.48        0.22   

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements. Note 3 presents additional information on consolidated earnings.


Table of Contents

3

 

Intertape Polymer Group Inc.

Consolidated Comprehensive Income

Periods ended September 30,

(In thousands of US dollars)

(Unaudited)

 

 

 

     Three months ended  
September 30, 
    Nine months ended  
September 30, 
 
                   2014                    2013                    2014                    2013   
                  

Net earnings

           6,011               14,419                29,759             13,732   
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income (loss)

        

Change in cumulative translation adjustments and Items that will be reclassified subsequently to net earnings

     (4,029     2,178        (4,408     (2,088)    
  

 

 

   

 

 

   

 

 

   

 

 

 

Remeasurement of defined benefit liability (net of income tax expense of $416, nil in 2013) (Note 13) and Items that will not be reclassified subsequently to net earnings

     1,045       -            1,045       -       
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income for the period

     3,027       16,597        26,396       11,644   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.


Table of Contents

4

 

Intertape Polymer Group Inc.

Consolidated Changes in Shareholders’ Equity

Nine months ended September 30, 2013

(In thousands of US dollars, except for number of common shares)

(Unaudited)

 

 

 

     Capital stock            Accumulated 
other 
      comprehensive 
income 
             
                   Number                     Amount                 Contributed 
surplus 
    Cumulative 
translation 
adjustment 
account 
                        Deficit      Total 
          shareholders’ 
equity 
 
                              

Balance as of December 31, 2012

           59,625,039                351,702                       16,386                         3,208                      (217,462)                     153,834   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Transactions with owners

              

Exercise of stock options (Note 10)

     1,151,610        3,760               3,760   

Excess tax benefit on exercised stock options

        1,962               1,962   

Stock-based compensation expense (Note 10)

           711           711   

Stock-based compensation expense credited to capital on options exercised (Note 10)

        1,709         (1,709 )         -      

Dividends on common stock (Note 10)

               (9,678 )     (9,678
  

 

 

    

 

 

    

 

 

     

 

 

   

 

 

 
     1,151,610        7,431         (998 )       (9,678 )     (3,245
  

 

 

    

 

 

    

 

 

     

 

 

   

 

 

 

Net earnings

               13,732       13,732   

Other comprehensive loss

              

Changes to cumulative translation adjustments

             (2,088       (2,088
          

 

 

   

 

 

   

 

 

 

Comprehensive income for the period

             (2,088     13,732       11,644   
          

 

 

   

 

 

   

 

 

 

Balance as of September 30, 2013

     60,776,649        359,133         15,388       1,120        (213,408 )     162,233   
  

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.


Table of Contents

5

 

Intertape Polymer Group Inc.

Consolidated Changes in Shareholders’ Equity

Nine months ended September 30, 2014

(In thousands of US dollars, except for number of common shares)

(Unaudited)

 

 

 

     Capital stock           Accumulated other
comprehensive
loss
             
     Number     Amount     Contributed
surplus
    Cumulative
translation
adjustment
account
    Deficit     Total shareholders’
equity
 
           $     $     $     $     $  

Balance as of December 31, 2013

     60,776,649       359,201        20,497       (770     (148,500 )     230,428   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Transactions with owners

            

Exercise of stock options (Note 10)

     235,427       694              694   

Excess tax benefit on exercised stock options

       680        (680 )         -      

Excess tax benefit on outstanding stock awards

         756           756   

Stock-based compensation expense (Note 10)

         1,880           1,880   

Stock-based compensation expense credited to capital on options exercised (Note 10)

       240        (240 )         -      

Repurchases of common stock (Note 10)

     (588,100 )     (3,176         (4,502 )     (7,678

Dividends on common stock (Note 10)

             (17,061 )     (17,061
  

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
     (352,673 )     (1,562     1,716         (21,563 )     (21,409
  

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

Net earnings

             29,759       29,759   

Other comprehensive income (loss)

            

Remeasurement of defined benefit liability (net of income tax expense of $416) (Note 13)

             1,045       1,045   

Changes to cumulative translation adjustments

           (4,408       (4,408
        

 

 

   

 

 

   

 

 

 

Comprehensive income for the period

           (4,408     30,804       26,396   
        

 

 

   

 

 

   

 

 

 

Balance as of September 30, 2014

     60,423,976       357,639        22,213       (5,178     (139,259 )     235,415   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.


Table of Contents

6

 

Intertape Polymer Group Inc.

Consolidated Cash Flows

Periods ended September 30,

(In thousands of US dollars)

(Unaudited)

 

 

 

     Three months ended  
September 30, 
    Nine months ended  
September 30, 
 
     2014      2013      2014      2013   
                  

OPERATING ACTIVITIES

        

Net earnings

     6,011        14,419        29,759        13,732   

Adjustments to net earnings

        

Depreciation and amortization

         6,800             6,932             19,492             20,841    

Income tax expense

     6,867        929        21,764        3,503   

Interest expense

     867        1,261        2,562        4,860   

Charges in connection with manufacturing facility closures, restructuring and other related charges

     73        150        182        23,469   

Stock-based compensation expense

     3,225        2,105        3,194        4,825   

Pension and other post-retirement benefits expense

     2,078        758        3,501        2,277   

(Gain) loss on foreign exchange

     317        (166     342        (146

Other adjustments for non cash items

     (27     (183     (48     (244

Income taxes paid, net

     (2,319     (424     (2,926     (494

Contributions to defined benefit plans

     (506     (790     (1,836     (2,823
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from operating activities before changes in working capital items

     23,386       24,991       75,986       69,800   
  

 

 

   

 

 

   

 

 

   

 

 

 

Changes in working capital items

        

Trade receivables

     (3,249     (1,551     (15,785     (11,315

Inventories

     (644     6,288        (15,809     (3,126

Parts and supplies

     240        (41     (142     (456

Other current assets

     (740     (143     (278     135   

Accounts payable and accrued liabilities

     10,811        3,617        8,587        1,783   

Provisions

     283        (139     560        2,434   
  

 

 

   

 

 

   

 

 

   

 

 

 
     6,701        8,031        (22,867     (10,545
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from operating activities

     30,087        33,022        53,119        59,255   
  

 

 

   

 

 

   

 

 

   

 

 

 

INVESTING ACTIVITIES

        

Purchases of property, plant and equipment

     (9,102     (10,515     (33,648     (34,516

Proceeds from disposals of property, plant and equipment

     1,785        1        1,876        1,646   

Other assets

     1        132        296        559   

Purchases of intangible assets

     (264     (100     (599     (171
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities

     (7,580     (10,482     (32,075     (32,482
  

 

 

   

 

 

   

 

 

   

 

 

 

FINANCING ACTIVITIES

        

Proceeds from long-term debt

     41,918        24,740        121,075        76,060   

Repayment of long-term debt

     (45,616     (44,748     (110,377     (90,917

Payments of debt issue costs

     -            (37     -            (139

Interest paid

     (995     (1,795     (2,871     (5,803

Proceeds from exercise of stock options

     4        109        694        3,771   

Repurchases of common stock

     (7,683     -            (7,683     -       

Dividends paid

     (7,196     (4,859     (16,998     (9,658
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities

     (19,568     (26,590     (16,160     (26,686
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash

     2,939        (4,050     4,884        87   

Effect of foreign exchange differences on cash

     (306     182        (305     (27

Cash, beginning of period

     4,446        9,819        2,500        5,891   
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash, end of period

     7,079        5,951        7,079        5,951   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.


Table of Contents

7

 

Intertape Polymer Group Inc.

Consolidated Balance Sheets

As of

(In thousands of US dollars)

 

 

 

     September 30, 
2014 
    (Unaudited) 
      December 31, 
2013 
(Audited) 
      

ASSETS

        

Current assets

        

Cash

       7,079         2,500  

Trade receivables

       93,381         78,543  

Inventories (Note 5)

       108,904         94,319  

Parts and supplies

       13,599         13,574  

Other current assets

       13,150         13,085  
    

 

 

     

 

 

 
       236,113         202,021  

Property, plant and equipment (Note 6)

       190,529         181,612  

Intangible assets

       1,641         1,597  

Deferred tax assets

       57,364         76,319  

Other assets

       3,385         3,650  
    

 

 

     

 

 

 

Total assets

       489,032         465,199  
    

 

 

     

 

 

 

LIABILITIES

        

Current liabilities

        

Accounts payable and accrued liabilities

       83,898         76,417  

Provisions (Note 9)

       547         1,865  

Installments on long-term debt (Note 8)

       8,215         8,703  
    

 

 

     

 

 

 
       92,660         86,985  

Long-term debt (Note 8)

       133,102         121,111  

Pension and other post-retirement benefits

       21,547         21,545  

Other liabilities

       740         1,250  

Provisions (Note 9)

       5,568         3,880  
    

 

 

     

 

 

 
       253,617         234,771  
    

 

 

     

 

 

 

SHAREHOLDERS’ EQUITY

        

Capital stock (Note 10)

       357,639         359,201  

Contributed surplus (Note 10)

       22,213         20,497  

Deficit

       (139,259 )       (148,500 )

Accumulated other comprehensive loss

       (5,178 )       (770 )
    

 

 

     

 

 

 
       235,415         230,428  
    

 

 

     

 

 

 

Total liabilities and shareholders’ equity

               489,032                 465,199  
    

 

 

     

 

 

 

 

 

The accompanying notes are an integral part of the interim condensed consolidated financial statements.


Table of Contents

8

 

Intertape Polymer Group Inc.

Notes to Interim Condensed Consolidated Financial Statements

September 30, 2014

(In US dollars, tabular amounts in thousands, except as otherwise noted)

(Unaudited)

 

 

 

1 - GENERAL BUSINESS DESCRIPTION

Intertape Polymer Group Inc. (the “Parent Company”), incorporated under the Canada Business Corporations Act, has its principal administrative offices in Montreal, Québec, Canada and in Sarasota, Florida, U.S.A. The address of the Parent Company’s registered office is 800 Place Victoria, Suite 3700, Montreal, Québec H4Z 1E9, c/o Fasken Martineau. The Parent Company’s common shares are listed on the Toronto Stock Exchange (“TSX”) in Canada.

The Parent Company and its subsidiaries (together referred to as the “Company”), develop, manufacture and sell a variety of paper and film based pressure sensitive and water activated tapes, polyethylene and specialized polyolefin films, woven coated fabrics and complementary packaging systems for industrial and retail use.

Intertape Polymer Group Inc. is the Company’s ultimate parent.

 

2 - ACCOUNTING POLICIES

Basis of Presentation and Statement of Compliance

The unaudited interim condensed consolidated financial statements (“financial statements”) present the Company’s consolidated balance sheets as of September 30, 2014 and December 31, 2013, as well as its consolidated earnings, comprehensive income and cash flows for the three and nine months ended September 30, 2014 and 2013, and the changes in shareholders’ equity for the nine months ended September 30, 2014 and 2013. These financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34 – Interim Financial Reporting and are expressed in United States (“US”) dollars. Accordingly, certain information and footnote disclosures normally included in annual audited consolidated financial statements prepared in accordance with International Financial Reporting Standards (“IFRS”), as issued by the International Accounting Standards Board (“IASB”), have been omitted or condensed.

These financial statements reflect all adjustments which are, in the opinion of management, necessary to present a fair statement of the results for these interim periods. These adjustments are of a normal recurring nature.

These financial statements were authorized for issuance by the Company’s Board of Directors on November 4, 2014.

Critical Accounting Judgments, Estimates and Assumptions

The preparation of the financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Significant changes in the underlying assumptions could result in significant changes to these estimates. Consequently, management reviews these estimates on a regular basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. The judgments, estimates and assumptions applied in the financial statements were the same as those applied in the Company’s most recent annual audited consolidated financial statements. The only exceptions are (i) the estimate of the provision for income taxes which is determined in the financial statements using the estimated weighted average annual effective income tax rate applied to the earnings before income tax expense (benefit) of the interim


Table of Contents

9

 

period and (ii) the re-measurement of the defined benefit liability which is required at year-end and if triggered by plan amendment or settlement during interim periods. These financial statements and notes should be read in conjunction with the Company’s most recent annual audited consolidated financial statements.

New Standards and Interpretations Issued But Not Yet Effective

Certain new standards, amendments and interpretations, and improvements to existing standards have been published by the IASB but are not yet effective, and have not been adopted early by the Company. Management anticipates that all of the relevant pronouncements will be adopted in the first reporting period following the date of application. Information on new standards, amendments and interpretations, and improvements to existing standards, which could potentially impact the Company’s consolidated financial statements, are detailed as follows:

Amended IAS 16 – Property, Plant and Equipment and Amended IAS 38 – Intangible Assets: Amended IAS 16 and IAS 38 were issued to clarify acceptable methods of depreciation and amortization. The new requirements are effective for annual periods beginning on or after January 1, 2016. Management has yet to assess the impact of these amendments on the Company’s consolidated financial statements.

IFRS 15 – Revenue from Contracts with Customers: IFRS 15 replaces IAS 18 – Revenue, IAS 11 – Construction Contracts and some revenue related interpretations. IFRS 15 establishes a new control-based revenue recognition model, changes the basis for deciding when revenue is recognized at a point in time or over time, provides new and more detailed guidance on specific topics and expands and improves disclosures about revenue. IFRS 15 is effective for annual reporting periods beginning on or after January 1, 2017. Management has yet to assess the impact of this new standard on the Company’s consolidated financial statements.

IFRS 9 (2014) – Financial Instruments: IFRS 9 (2014) replaces IAS 39 – Financial Instruments: Recognition and Measurement. IFRS 9 (2014) addresses accounting for financial assets and financial liabilities, classification and measurement, recognition and derecognition, hedge accounting and impairment. IFRS 9 is effective for annual reporting periods beginning on or after January 1, 2018. Management has yet to assess the impact of this new standard on the Company’s consolidated financial statements.

Certain other new standards and interpretations have been issued but are not expected to have a material impact on the Company’s financial statements.

 

3 - INFORMATION INCLUDED IN CONSOLIDATED EARNINGS

 

     Three months ended  
September 30, 
   Nine months ended  
September 30, 
                   2014                   2013                   2014                   2013 
             

Employee benefit expense

                   

Wages, salaries and other short-term benefits

             34,845                32,031                103,833                101,403  

Stock-based compensation expense

       3,225          2,105          3,194          4,825  

Pensions and other post-retirement benefits – defined benefit plans

       2,104          784          3,579          2,359  

Pensions and other post-retirement benefits – defined contribution plans

       985          900          2,991          2,761  
    

 

 

      

 

 

      

 

 

      

 

 

 
       41,159          35,820          113,597          111,348  
    

 

 

      

 

 

      

 

 

      

 

 

 


Table of Contents

10

 

     Three months ended  
September 30, 
    Nine months ended  
September 30, 
 
                   2014                    2013                     2014                    2013   
                  

Finance costs - Interest

        

Interest on long-term debt

           978       1,144        2,970       4,356   

Amortization of debt issue costs on long-term debt

     153       288        460       879   

Interest capitalized to property, plant and equipment

     (264 )     (171     (868 )     (375
  

 

 

   

 

 

   

 

 

   

 

 

 
     867             1,261              2,562             4,860   
  

 

 

   

 

 

   

 

 

   

 

 

 

Finance costs - Other expense, net

        

Foreign exchange (gain) loss

     316       (168     342       (147

Other costs, net

     110       358        806       934   
  

 

 

   

 

 

   

 

 

   

 

 

 
     426       190        1,148       787   
  

 

 

   

 

 

   

 

 

   

 

 

 

Additional information

        

Depreciation of property, plant and equipment

     6,610       6,763        18,950       20,326   

Amortization of intangible assets

     190       169        542       515   

Impairment (reversal) of long-term assets

     34       1,387        (257 )     23,479   

(Gain) loss on disposal of property, plant and equipment

     (194 )     74        (86 )     132   

 

4 - MANUFACTURING FACILITY CLOSURES, RESTRUCTURING, AND OTHER RELATED CHARGES

The following table describes the charges incurred by the Company in connection with its restructuring efforts, which are included in the Company’s consolidated earnings for the three and nine months ended September 30, 2014 and 2013 under the caption manufacturing facility closures, restructuring and other related charges:

 

     Three months ended 
September 30, 2014 
    Nine months ended 
September 30, 2014 
 
     South 
    Carolina 
project 
    Other 
    projects 
             Total      South 
    Carolina 
project 
    Other 
    projects 
             Total   
                            

Impairment (reversal) of property, plant and equipment

     (398 )     397         (1 )     (395     103        (292

Impairment of parts and supplies

     -            -             -            -            77        77   

Equipment relocation

     1,074       4         1,078       1,672        462        2,134   

Write-down of inventories to net realizable value

     15       -             15       20        54        74   

Severance and other labor related costs

     376       1         377       1,202        272        1,474   

Idle facility costs

     -            90         90       -            475        475   

Other costs

     1       -             1       18        4        22   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 
           1,068             492               1,560             2,517              1,447              3,964   
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

    

 

 

 


Table of Contents

11

 

     Three months ended 
September 30, 2013 
    Nine months ended 
September 30, 2013 
 
     South 
    Carolina 
project 
    Other 
   projects 
                Total      South 
     Carolina 
project 
     Other 
    projects 
            Total   
                           

Impairment (reversal) of property, plant and equipment

     (33 )     110        77       22,180         (166 )     22,014   

Impairment (reversal) of parts and supplies

     -            24        24       1,312         (7 )     1,305   

Equipment relocation

     130       213        343       130         1,785       1,915   

Write-down (reversal) of inventories to net realizable value

     22       (43     (21 )     22         (121 )     (99

Severance and other labor related costs

     373       (31     342       576         31       607   

Environmental costs

     -            -            -            2,522         -            2,522   

Idle facility costs

     -            144        144       -             677       677   

Other costs (reversals)

     26       (1     25       84         34       118   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 
     518       416        934       26,826         2,233       29,059   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

   

 

 

 

On February 26, 2013, the Company announced its intention to relocate its Columbia, South Carolina manufacturing facility within the region in order to modernize facility operations and acquire state-of-the-art manufacturing equipment. The charges incurred are included in the tables above under South Carolina project.

In 2014 and 2013, the charges incurred in the table above under other projects are the incremental costs of the ongoing Richmond, Kentucky manufacturing facility closure, consolidation of the shrink film production from Truro, Nova Scotia to Tremonton, Utah and other small restructuring initiatives.

 

5 - INVENTORIES

 

                September 30, 
2014 
         December 31, 
2013 
 
           

Raw materials

     32,762         29,389   

Work in process

     20,254         18,206   

Finished goods

     55,888        46,724   
  

 

 

    

 

 

 
              108,904                   94,319   
  

 

 

    

 

 

 

The amount of inventories recognized as an expense during the period is included in the statement of consolidated earnings under the caption cost of sales.

 

6 - PROPERTY, PLANT AND EQUIPMENT

During the three and nine months ended September 30, 2014, acquisitions of property, plant and equipment amounted to $9.1 million and $33.6 million, respectively ($10.5 million and $34.5 million for the three and nine months ended September 30, 2013, respectively). During the three and nine months ended September 30, 2014, the net book value of property, plant and equipment disposals amounted to $1.5 million and $1.8 million, respectively (less than $0.1 million and $1.6 million for the three and nine months ended September 30, 2013, respectively) and the gain on those disposals amounted to $0.2 million and $0.1 million, respectively (loss on disposals of less than $0.1 million loss for both the three and nine months ended September 30, 2013).


Table of Contents

12

 

On June 28, 2013, in connection with the relocation of the Columbia, South Carolina manufacturing facility, the Company purchased real estate including land and building of $11.3 million in Blythewood, South Carolina. As of September 30, 2014, the purchased real estate including land and building and improvements thereon to prepare for its intended use placed into service totalled $16.7 million.

As of September 30, 2014 and December 31, 2013, the Company had commitments to purchase machines and equipment totaling $8.6 million and $12.9 million, respectively.

During both the three and nine months ended September 30, 2014, the Company recorded impairments on idle assets of less than $0.1 million (less than $0.1 million and $0.2 million for the three and nine months ended September 30, 2013, respectively) that were included in the statement of consolidated earnings under the caption cost of sales and the statement of consolidated cash flows under the caption other adjustments for non-cash items. There were no reversals of impairments, other than those disclosed in Note 4 and included in the statement of consolidated earnings under the caption manufacturing facility closures, restructuring and other related charges.

 

7 - INCOME TAXES

Income tax expense (benefit) is recognized in each interim period based on the best estimate of the weighted average annual income tax rate expected for the full financial year. Amounts accrued for income tax expense (benefit) in one interim period may have to be adjusted in a subsequent interim period of the financial year if the estimate of the annual income tax rate changes.

On October 30, 2014, the Company completed the final steps of a multi-step plan to reorganize the capital structure of several of its legal entities (“Legal Entity Reorganization”) in order to more efficiently manage its intercompany debt. The Company incurred $2.5 million of upfront income tax expense in the third quarter of 2014 as a result of the completion of various steps within the Legal Entity Reorganization plan. On October 30, 2014, the Company incurred an additional $0.3 million of upfront income tax expense upon the completion of the final steps of the Legal Entity Reorganization plan.

The effective tax rate for the three and nine months ended September 30, 2014 was 53.3% and 42.2%, respectively (6.1% and 20.3% for the three and nine months ended September 30, 2013, respectively). The increase in effective tax rate between the three months ended September 30, 2014 and 2013 was primarily due to the utilization of US deferred tax assets that were previously derecognized until the fourth quarter of 2013 and the $2.5 million upfront income tax expense related to the Legal Entity Reorganization.

The increase in effective tax rate between the nine months ended September 30, 2014 and 2013 was primarily due to the utilization of US deferred tax assets that were previously derecognized until the fourth quarter of 2013 and the $2.5 million upfront income tax expense related to the Legal Entity Reorganization. These increases were partially offset by the income tax effect of stock options exercised during the first nine months of 2013.


Table of Contents

13

 

8 - LONG-TERM DEBT

 

                 September 30, 
2014 
         December 31, 
2013 
 
           

Asset-based loan facility (“ABL facility”) (1)

     92,611        78,159   

Real estate secured term loan (“Real Estate Loan”) (1)

     13,157        14,278   

Finance lease liabilities

     26,613        26,468   

Mortgage and other loans (1)

     8,936        9,602   

Equipment finance agreement advance fundings

     -             1,307   
  

 

 

    

 

 

 
     141,317        129,814   

Less: Installments on long-term debt

     8,215        8,703   
  

 

 

    

 

 

 
            133,102                121,111   
  

 

 

    

 

 

 

 

(1) 

The ABL facility, Real Estate Loan and mortgage and other loans are presented net of unamortized related debt issue costs totalling $1.5 million ($1.9 million as of December 31, 2013).

As of September 30, 2014 and December 31, 2013, the effective interest rate on borrowings under the ABL facility was 2.97% and 2.89%, respectively.

The Company’s unused availability under the ABL facility as of September 30, 2014 and December 31, 2013 was $53.2 million and $47.8 million, respectively.

The ABL facility has one financial covenant, a fixed charge ratio of greater than or equal to 1.0 to 1.0. The financial covenant becomes effective only when unused availability drops below $25.0 million. A default under the ABL facility would be deemed a default under the Real Estate Loan, the secured debt equipment finance agreement noted below and the mortgage loan entered into in connection with the Company’s real estate purchase in Blythewood, South Carolina.

On August 14, 2012, the Company entered into a secured debt equipment finance agreement (the “Equipment Finance Agreement”). The Company entered into the final schedule on March 26, 2014. As of September 30, 2014 and December 31, 2013, advance fundings under the Equipment Finance Agreement, which are amounts funded and borrowed but not yet scheduled, were nil and $1.3 million, respectively. Advance fundings accrued interest at the 30-day LIBOR rate plus 200 basis points.

The Real Estate Loan contains two financial covenants and prepayment conditions. These covenants are determined at the end of each fiscal month, and the Company has been in compliance with these covenants since entering into the Real Estate Loan.

 

9 - PROVISIONS AND CONTINGENT LIABILITIES

 

             Environmental                 Restoration                    Severance 
and other 
                      Total   
                   

Balance, December 31, 2013

     2,518        1,674        1,553       5,745   

Additional provisions

     -             460        1,922       2,382   

Amounts used

     -             (565     (779 )     (1,344

Amounts reversed

     -             (594     (18 )     (612

Net foreign exchange differences

     -             (40     (16 )     (56
  

 

 

    

 

 

   

 

 

   

 

 

 

Balance, September 30, 2014

     2,518        935                        2,662                   6,115   
  

 

 

    

 

 

   

 

 

   

 

 

 

Amount presented as current

     -             -            547       547   

Amount presented as non-current

     2,518        935        2,115       5,568   
  

 

 

    

 

 

   

 

 

   

 

 

 

Balance, September 30, 2014

                       2,518                          935        2,662       6,115   
  

 

 

    

 

 

   

 

 

   

 

 

 


Table of Contents

14

 

In 2013, the Company began the process to relocate the Langley, British Columbia manufacturing facility to a new nearby location due to the expiration of the non-renewable lease in April 2014. As a result, in 2014, the Company recorded an additional restoration provision for the new location where the Company is obligated to restore the leased property to the same condition that existed at the time of the lease commencement date. In addition, the Company reversed a portion of the outstanding restoration provision of the existing facility based on actual costs incurred. The reversal is included in the statement of consolidated earnings under the caption cost of sales and reduced depreciation and amortization. The carrying amounts of these obligations are based on management’s best estimate of the costs of the permanent removal of the Company’s manufacturing equipment used in these facilities.

A portion of the provision recorded in severance and other provisions primarily relates to the Columbia, South Carolina manufacturing facility closure. Refer to Note 4 for more information.

On July 3, 2014, the Company’s prior Chief Financial Officer filed a complaint with the Occupational Safety and Health Administration of the U.S. Department of Labor (“OSHA”) alleging certain violations by the Company related to the terms of his employment and his termination. The Company has filed its response to the complaint with OSHA. The Company believes that these allegations and claims are without merit and intends to vigorously defend them. Because the proceeding is currently in its initial stages, the Company is not currently able to predict the probability of a favorable or unfavorable outcome, or the amount of any possible loss in the event of an unfavorable outcome. Consequently, no material provision or liability has been recorded for these allegations and claims as of September 30, 2014. Approximately $0.4 million of the additional provision recorded in the first quarter of 2014 in severance and other provisions is for an estimated amount relating to the prior Chief Financial Officer based on the employment letter agreements entered into on October 30, 2009 and November 17, 2009.

The Company is also engaged from time-to-time in various legal proceedings and claims that have arisen in the ordinary course of business. The outcome of all of the proceedings and claims against the Company is subject to future resolution, including the uncertainties of litigation. Based on information currently known to the Company and after consultation with outside legal counsel, management believes that the probable ultimate resolution of any such proceedings and claims, individually or in the aggregate, will not have a material adverse effect on the financial condition of the Company, taken as a whole, and accordingly, no amounts have been recorded as of September 30, 2014.

 

10 - CAPITAL STOCK AND EARNINGS PER SHARE

Common Shares

The Company’s common shares outstanding as of September 30, 2014 and December 31, 2013 were 60,423,976 and 60,776,649, respectively.

Share Repurchases

On July 7, 2014, the Company announced a normal course issuer bid (“NCIB”) effective on July 10, 2014. In connection with this NCIB, the Company is entitled to repurchase for cancellation up to 2,000,000 of the Company’s common shares issued and outstanding. The NCIB will expire on July 9, 2015.

As of September 30, 2014, the Company has repurchased 588,100 common shares at an average price of CDN$14.30 per share, including commissions, for a total purchase price of $7.7 million. The excess of the purchase price paid over the carrying value of the common shares repurchased of $4.5 million was recorded in deficit in the consolidated balance sheet and statement of consolidated changes in shareholders’ equity as the share repurchase premium.


Table of Contents

15

 

Earnings Per Share

The weighted average number of common shares outstanding for the three and nine months ended September 30, 2014 and 2013 are as follows:

 

     Three months ended 
September 30, 
     Nine months ended 
September 30, 
 
                         2014                           2013                           2014                           2013   

Basic

     60,790,184         60,731,173        60,804,653         60,245,708   

Effect of stock options

     1,438,997         1,341,410        1,027,522         1,223,470   

Effect of performance share units

     228,750         -             93,008         -       
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted

         62,457,931             62,072,583            61,925,183             61,469,178   
  

 

 

    

 

 

    

 

 

    

 

 

 

Deferred Shared Units (“DSUs”) are not contingently issuable shares since the shares are issuable solely after the passage of time. As such, DSUs are treated as outstanding and included in the calculation of weighted average basic common shares.

Performance Share Units (“PSUs”) are contingently issuable shares since the shares are issuable only after certain service and market-based performance conditions are satisfied. PSUs are treated as outstanding and included in the calculation of weighted average basic common shares only after the date when these conditions are satisfied at the end of the vesting period.

PSUs are treated as outstanding and included in the calculation of weighted average diluted common shares, to the extent they are dilutive, when the applicable performance conditions have been satisfied as of the reporting period end date. PSUs granted during the period ending September 30, 2014 did meet the performance conditions as of September 30, 2014 and were included in the calculation of weighted average diluted common shares outstanding.

Common shares repurchased under the NCIB are deducted in the calculation of basic and diluted average number of common shares based on the trade settlement date.

For the three and nine months ended September 30, 2014, the number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 32,500 for both periods (32,500 and 780,000 for the three and nine months ended September 30, 2013, respectively).

Dividends

On February 6, 2014, the Company declared a cash dividend of $0.08 per common share paid on March 31, 2014 to shareholders of record at the close of business on March 19, 2014. The aggregate amount of this dividend payment was $4.9 million based on 60,776,649 shares of the Company’s common shares issued and outstanding as of March 19, 2014.

On May 7, 2014, the Company declared a cash dividend of $0.08 per common share paid on June 30, 2014 to shareholders of record at the close of business on June 17, 2014. The aggregate amount of this dividend payment was $4.9 million based on 60,951,976 shares of the Company’s common shares issued and outstanding as of June 17, 2014.

On July 7, 2014, the Company’s Board of Directors approved a change in the quarterly dividend policy by increasing the dividend from $0.08 to $0.12 per share. Accordingly, on August 5, 2014, the Company declared a cash dividend of $0.12 per common share paid on September 30, 2014 to shareholders of record at the close of business on September 15, 2014. The aggregate amount of this dividend payment was $7.2 million based on 60,423,976 shares of the Company’s common shares issued and outstanding as of September 15, 2014.


Table of Contents

16

 

Stock Appreciation Rights

As of September 30, 2014, 945,905 Stock Appreciation Rights (“SARs”) were outstanding. The weighted average fair value per SAR outstanding was estimated as $6.96 using the Black-Scholes option pricing model, taking into account the following weighted average assumptions:

 

Expected life

     3.8 years   

Expected volatility

     35%   

Risk-free interest rate

     1.41%   

Expected dividends

     3.29%   

Stock price at grant date

     CDN$7.56   

Exercise price of awards

     CDN$7.56   

Stock price

     CDN$16.27   

Foreign exchange rate USD to CDN

     1.1136   

Expected volatility was calculated by applying a weighted average of the daily closing price change on the TSX for a term commensurate with the expected life of each grant, with more weight placed on the more recent time periods.

During the three and nine months ended September 30, 2014, $2.5 million and $1.3 million of expense is included under the caption selling, general and administrative expenses, respectively ($1.7 million and $4.1 million of expense for the three and nine months ended September 30, 2013, respectively). The corresponding liability is recorded on the Company’s consolidated balance sheets respectively under the caption accounts payable and accrued liabilities for amounts vested and expected to vest in the next 12 months, and other liabilities for amounts expected to vest in greater than 12 months.

During the three and nine months ended September 30, 2014, 58,750 and 100,000 SARs were exercised at an exercise price of CDN$7.56, resulting in cash payments of $0.4 million and $0.6 million, respectively (28,750 and 41,250 SARs were exercised at an exercise price of CDN$7.56, resulting in cash payments of $0.2 million and $0.3 million for the three and nine months ended September 30, 2013, respectively).

During the three and nine months ended September 30, 2014, nil and 123,750 SARs were forfeited, respectively (nil and 30,000 SARs were forfeited for the three and nine months ended September 30, 2013, respectively).

Stock Options

During the three and nine months ended September 30, 2014, nil and 492,500 stock options were granted at a weighted average exercise price of nil and CDN$12.51 and a weighted average fair value of nil and $3.12, respectively (82,500 and 830,000 stock options were granted at a weighted average exercise price of CDN$13.53 and CDN$12.19 and a weighted average fair value of $3.96 and $3.69 for the three and nine months ended September 30, 2013, respectively).


Table of Contents

17

 

During the three and nine months ended September 30, 2014 and 2013, the weighted average fair value of stock options granted was estimated using the Black-Scholes option pricing model, taking into account the following weighted average assumptions:

 

     Three months ended  
September 30, 
     Six months ended  
September 30, 
 
     2014       2013       2014       2013   

Expected life

                        N/A          5.0 years          5.7 years          5.6 years    

Expected volatility

     N/A          42%          38%          43%    

Risk-free interest rate

     N/A          1.84%          1.75%          1.59%    

Expected dividends

     N/A          2.48%          2.83%          2.72%    

Stock price at grant date

     N/A          CDN$13.53          CDN$12.51          CDN$12.19    

Exercise price of awards

     N/A          CDN$13.53          CDN$12.51          CDN$12.19    

Foreign exchange rate USD to CDN

     N/A          1.0446          1.1070          1.0358    

Expected volatility was calculated by applying a weighted average of the daily closing price change on the TSX for a term commensurate with the expected life of each grant, with more weight placed on the more recent time periods.

During the three and nine months ended September 30, 2014, 2,500 and 235,427 stock options were exercised at a weighted average exercise price of CDN$1.80 and CDN$3.19, resulting in cash proceeds to the Company of less than $0.1 million and $0.7 million, respectively (80,000 and 1,151,610 stock options were exercised at a weighted average exercise price of CDN$1.77 and CDN$3.35, resulting in cash proceeds to the Company of $0.1 million and $3.8 million for the three and nine months ended September 30, 2013, respectively).

During the three and nine months ended September 30, 2014, nil and 140,000 stock options expired or were forfeited, respectively (50,000 and 71,250 stock options were forfeited for the three and nine months ended September 30, 2013, respectively).

As of September 30, 2014, 2,381,250 stock options were outstanding. The weighted average exercise price and fair value at grant date per stock option outstanding as of September 30, 2014 was CDN$7.02 and $2.27, respectively.

Performance Share Unit Plan

On June 11, 2014, the Board of Directors of the Company adopted the PSU Plan. The purpose of the PSU Plan is to provide participants with a proprietary interest in the Company to (a) increase the incentives of those participants who share primary responsibility for the management, growth and protection of the business of the Company, (b) furnish an incentive to such participants to continue their services for the Company and (c) provide a means through which the Company may attract potential employees. The PSU Plan is administered by the Compensation Committee of the Board of Directors of the Company and authorizes the Company to award PSUs to eligible persons. A PSU, as defined by the Company’s PSU Plan, represents the right of a participant, once such PSU is earned and has vested in accordance with the PSU Plan, to receive the number of common shares of the Company underlying the PSU. Furthermore, a participant will receive a cash payment from the Company upon PSU settlement that is equivalent to the number of shares issued or delivered to the participant multiplied by the amount of cash dividends per share declared by the Company between the date of grant and the third anniversary of the grant date. PSUs are net-settled to satisfy minimum statutory tax withholding requirements.

PSUs are expensed straight-line over their vesting period. The fair value of the PSU is based on the close price for the common shares of the Company on the TSX on the date of the grant adjusted for market-based performance conditions.

On June 11, 2014, 152,500 PSUs were granted. The PSUs are earned over a three year period with vesting at the third anniversary of the grant date. The number of shares earned can range from 0 to 150%


Table of Contents

18

 

of the grant amount based on entity performance criteria, specifically the total shareholder return ranking versus a specified peer group of companies. During the three months ended September 30, 2014 there were no PSUs granted.

Deferred Share Unit Plan

On June 11, 2014, the Board of Directors of the Company adopted the DSU Plan. The purpose of the DSU Plan is to provide participants with a form of compensation which promotes greater alignment of the interests of the participants and the shareholders of the Company in creating long-term shareholder value. The DSU Plan is administered by the Compensation Committee of the Board of Directors of the Company and authorizes the Company to award DSUs to any member of the Board of Directors of the Company that is not an executive officer or employee of the Company. A DSU, as defined by the Company’s DSU Plan, represents the right of a participant to receive a common share of the Company. Under the DSU Plan, each director is entitled to receive DSUs as a result of a grant and/or in lieu of cash for semi-annual directors’ fees. DSUs are settled when the director ceases to be a member of the Board of Directors of the Company. DSUs are net-settled to satisfy minimum statutory tax withholding requirements.

DSUs received as a result of a grant are expensed immediately. The fair value of DSUs is based on the close price for the common shares of the Company on the Toronto Stock Exchange on the date of the grant.

DSUs received in lieu of cash for directors’ fees are expensed as earned over the service period. The fair value of DSUs is based on the fair value of services rendered.

During the three and nine months ended September 30, 2014, there were 15,901 and 36,901 DSUs granted, respectively.

Change in Contributed Surplus

The activity for the three and nine months ended September 30, 2014 in the consolidated changes in shareholders’ equity under the caption contributed surplus is detailed as follows:

 

     There months ended  
September 30, 
    Nine months ended  
September 30, 
 
                     2014                      2013                      2014                      2013   
                  

Excess tax benefit on exercised stock options

     (8 )     -            (680 )     -       
  

 

 

   

 

 

   

 

 

   

 

 

 

Excess tax benefit on outstanding stock options

     1,498       -            756       -       
  

 

 

   

 

 

   

 

 

   

 

 

 

Stock-based compensation expense credited to capital on options exercised

                  (2     (258     (240     (1,709
  

 

 

   

 

 

   

 

 

   

 

 

 

Stock-based compensation expense

        

Stock options

     399        421        1,160        711   

Deferred share units

     148        -            526        -       

Performance share units

     148        -            194        -       
  

 

 

   

 

 

   

 

 

   

 

 

 
     695        421                  1,880        711   
  

 

 

   

 

 

   

 

 

   

 

 

 

Change in contributed surplus

     2,183                   163        1,716                  (998
  

 

 

   

 

 

   

 

 

   

 

 

 

 

11 - RELATED PARTY TRANSACTIONS

In June 2014, the Company engaged with a relocation management company to facilitate the purchase of the newly appointed Chief Financial Officer’s home in Montreal, Québec, Canada to assist in the relocation to Sarasota, FL, U.S.A. The Company provided funding to the relocation management company to purchase the home for $0.9 million. Upon the sale of the home, the Company will be reimbursed for the purchase funding. As of September 30, 2014 the home is for sale and included in the consolidated balance sheet under the caption other current assets.


Table of Contents

19

 

12 - COMMITMENTS AND CONTINGENCIES

As noted in the June 30, 2014 Interim Condensed Consolidated Financial Statements, the Company entered into agreements with various raw material suppliers to purchase minimum quantities of certain raw materials at fixed rates through December 2015 totaling approximately $6.2 million as of September 30, 2014. The Company is also required by the agreements to pay any storage costs incurred by the applicable supplier in the event the Company delays shipment in excess of 30 days. In the event the Company defaults under the terms of an agreement, an arbitrator will determine fees and penalties due to the applicable supplier. Neither party shall be liable for failure to perform for reasons of Force Majeure as defined within the agreements. The Company currently knows of no event, trend or uncertainty that may affect the availability or benefits of the agreement.

As noted in the June 30, 2014 Interim Condensed Consolidated Financial Statements, the Company entered into agreements with various utility suppliers to fix certain energy costs through October 2017 for minimum amounts of consumption at several of its manufacturing facilities. The Company estimates that utility billings will total approximately $4.5 million over the term of the contracts based on the contracted fixed terms and current market rate assumptions. The Company is also required by the agreements to pay any difference between the fixed price agreed to with the utility and the sales amount received by the utility for resale to a third party if the Company fails to meet the minimum consumption required by the agreements. In the event of early termination the Company is required to pay the utility suppliers the difference between the contracted amount and the current market value of the energy, adjusted for present value, of any future agreed upon minimum usage. Neither party shall be liable for failure to perform for reasons of Force Majeure as defined within the agreements. The Company currently knows of no event, trend or uncertainty that may affect the availability or benefits of the agreements.

 

13 - PENSION AND OTHER POST-RETIREMENT BENEFIT PLANS

Effective September 30, 2011, the defined benefit plan associated with the former Brantford, Ontario manufacturing facility sponsored by the Company was wound-up. Pursuant to applicable legislation, benefits for this plan must be settled within the five-year period following the wind-up effective date. Effective July 31, 2014, the Company purchased a group annuity buy out policy to settle the majority of its obligation to plan participants. During the three and nine months ended September 30, 2014, the Company recognized settlement losses of $1.3 million for both periods resulting from the difference between the accounting liability and the cost to settle the obligations. The settlement losses were included in the statement of consolidated earnings under the caption cost of sales. The Company was required to re-measure the plan’s assets and liabilities as of the settlement date resulting in a decrease of $1.5 million under the pension and other post-retirement benefits in the consolidated balance sheet with the offset flowing through other comprehensive income, net of income tax expense, and in deficit.

The remaining obligations are expected to be settled during the fourth quarter of 2014 and are expected to result in an additional settlement loss of up to approximately $0.7 million. The Company expects a minimal impact on its cash flows as a result of the settlement.

 

14 - POST REPORTING EVENTS

Adjusting Events

No adjusting events have occurred between the reporting date of these financial statements and the date of authorization.

Non-Adjusting Events

On November 4, 2014, the Company declared a cash dividend of $0.12 per common share payable on December 31, 2014 to shareholders of record at the close of business on December 15, 2014. The estimated amount of this dividend payment is $7.3 million based on 60,423,976 shares of the Company’s common shares issued and outstanding as of November 4, 2014.


Table of Contents

20

 

The Company had a $1.8 million mortgage loan on its owned real estate in Bradenton, Florida. On October 7, 2014, the Company prepaid in full the remaining $1.5 million on the note which was originally due September 28, 2028. There was a corresponding write-off of debt issue costs of $0.1 million which was recorded as interest expense under the caption finance costs in the statement of consolidated earnings. The mortgage loan had a net book value of $1.4 million as of December 31, 2013 and September 30, 2014.

On October 30, 2014, the Company completed the final steps of the Legal Entity Reorganization plan in order to more efficiently manage its intercompany debt and incurred an additional $0.3 million of upfront income tax expense as a result of these final steps. This reorganization is expected to impact the Company’s effective tax rate in future periods due to an ongoing annual income tax benefit of approximately $7 million beginning on October 30, 2014.

No other significant non-adjusting events have occurred between the reporting date of these financial statements and the date of authorization.